ES2170878T3 - Compuestos de o-carbamoil-fenilalaninol y sus sales farmaceuticamente utiles. - Google Patents

Compuestos de o-carbamoil-fenilalaninol y sus sales farmaceuticamente utiles.

Info

Publication number
ES2170878T3
ES2170878T3 ES96935553T ES96935553T ES2170878T3 ES 2170878 T3 ES2170878 T3 ES 2170878T3 ES 96935553 T ES96935553 T ES 96935553T ES 96935553 T ES96935553 T ES 96935553T ES 2170878 T3 ES2170878 T3 ES 2170878T3
Authority
ES
Spain
Prior art keywords
hydrogen
compounds
carbamoil
pharmaceutically acceptable
cycling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96935553T
Other languages
English (en)
Inventor
Yong Moon Choi
Dong Il Han
Yong Kil Kim
Hun Woo Shin
Jeong Han Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK CORP
SK Corp
Original Assignee
SK CORP
SK Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK CORP, SK Corp filed Critical SK CORP
Application granted granted Critical
Publication of ES2170878T3 publication Critical patent/ES2170878T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN COMPUESTO DE O CARBAMOIL - FENILALANINOL, ENRIQUECIDO RACEMICA O ENANTIOMERICAMENTE, REPRESENTADO POR LA FORMULA ESTRUCTURAL (V) Y A SUS SALES FARMACEUTICAMENTE ACEPTABLES, PARA TRATAR ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL, SIENDO PH UN GRUPO FENILO, TAL Y COMO SE DESCRIBE EN LA FORMULA (A); SIENDO R UN MIEMBRO SELECCIONADO A PARTIR DEL GRUPO FORMADO POR HIDROGENO, ALQUILO INFERIOR DE 1 A 8 ATOMOS DE CARBONO, HALOGENO SELECCIONADO A PARTIR DE F, CL, BR Y I, ALCOXI DE 1 A 3 ATOMOS DE CARBONO, NITRO, HIDROXILO, TRIFLUOROMETILO Y TIOALCOXI DE 1 A 3 ATOMOS DE CARBONO, Y X ES UN ENTERO COMPRENDIDO ENTRE 1 Y 3, CON LA CONDICION DE QUE R ES IGUAL O DIFERENTE CUANDO X ES 2 O 3, R 1 Y R 2 PUEDEN SER IGUALES O DIFERENTES ENTRE SI, Y SE SELECCIONAN INDEPENDIENTEMENTE A PARTIR DEL GRUPO FORMADO POR HIDROGENO, ALQUILO INFERIOR DE 1 A 8 ATOMOS DE CARBONO, ARILO, ARILALQUILO, PROPILO CICLICO Y COMPUESTOS CICLICOS ALIFATICOS DE 5 A 7 MIEMBROS; Y R 1 Y R 2 PUEDEN ESTAR UNIDOS PARA FORMAR UN COMPUESTO CICLICO DE 5 A 7 MIEMBROS QUE PUEDE COMPRENDER ENTRE CERO Y UN ATOMO DE NITROGENO ADICIONAL, SUSTITUIDO CON UN MIEMBRO SELECCIONADO A PARTIR DEL GRUPO FORMADO POR HIDROGENO, Y GRUPOS ALQUILO O ARILO, O ENTRE CERO Y UN ATOMO DE OXIGENO NO CONECTADOS DIRECTAMENTE, EXCLUYENDO EL CASO EN EL QUE R, R 1 Y R 2 SON TODOS HIDROGENO. SE INCLUYEN ASIMISMO LAS SALES FARMACEUTICAMENTE ACEPTABLES DE DICHOS COMPUESTOS. LA PRESENTE INVENCION SE REFIERE TAMBIEN A LOA COMPUESTOS DE O - CARBAMOIL - FENILALANINOL, REPRESENTADOS MEDIANTE LA FORMULA GENERAL (IX), DONDE PH, R 1 Y R 2 SE HAN DESCRITO ANTERIO RMENTE, ASI COMO LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS.
ES96935553T 1996-10-10 1996-10-10 Compuestos de o-carbamoil-fenilalaninol y sus sales farmaceuticamente utiles. Expired - Lifetime ES2170878T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002240060A CA2240060C (en) 1996-10-10 1996-10-10 O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
PCT/KR1996/000174 WO1998015526A1 (en) 1996-10-10 1996-10-10 O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
CN96198889A CN1076016C (zh) 1996-10-10 1996-10-10 O－氨基甲酰基－苯丙胺醇化合物、其药学上有用的盐和它们的制备方法

Publications (1)

Publication Number Publication Date
ES2170878T3 true ES2170878T3 (es) 2002-08-16

Family

ID=27170728

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96935553T Expired - Lifetime ES2170878T3 (es) 1996-10-10 1996-10-10 Compuestos de o-carbamoil-fenilalaninol y sus sales farmaceuticamente utiles.

Country Status (9)

Country Link
EP (1) EP0873308B1 (es)
JP (1) JP4068154B2 (es)
CN (1) CN1076016C (es)
CA (1) CA2240060C (es)
DE (1) DE69618663T2 (es)
DK (1) DK0873308T3 (es)
ES (1) ES2170878T3 (es)
PT (1) PT873308E (es)
WO (1) WO1998015526A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE264844T1 (de) * 1999-02-04 2004-05-15 Sk Corp Tetrahydroisochinolinalkanol-derivate und diese enthaltende pharmazeutische zubereitungen
US20050080268A1 (en) * 2003-10-08 2005-04-14 Yong-Moon Choi Process of preparing O-carbamoyl compounds in the presence of active amine group
EP1890684B1 (en) * 2005-06-08 2013-08-14 SK Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
BRPI0719275A2 (pt) * 2006-10-13 2014-04-29 Janssen Pharmaceutica Nv Composições de carbamatos de fenil-alquil-amino
KR20120098578A (ko) 2009-06-22 2012-09-05 에스케이바이오팜 주식회사 피로의 치료 또는 예방 방법
US8232315B2 (en) * 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
EP2496227B1 (en) * 2009-11-06 2019-05-22 SK Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
BR112012010670A2 (pt) 2009-11-06 2016-04-12 Sk Biopharmaceuticals Co Ltd métodos para tratamento de distúrbio de défict de atenção/hiperatividade
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) * 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
CA2905457A1 (en) 2013-03-13 2014-10-09 Aerial Biopharma, Llc Treatment of cataplexy
CA2917702A1 (en) 2013-07-18 2015-01-22 Jazz Pharmaceuticals International Iii Limited Treatment for obesity
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
BR112019025286A2 (pt) 2017-06-02 2020-06-23 Jazz Pharmaceuticals Ireland Limited Métodos e composições para tratamento de sonolência excessiva
JP7366002B2 (ja) * 2017-07-31 2023-10-20 ジャズ ファーマシューティカルズ アイルランド リミテッド カルバモイルフェニルアラニノール類縁体およびその使用
CN110655500B (zh) * 2018-06-28 2020-12-08 浙江京新药业股份有限公司 氨基甲酸酯衍生物及其制备方法和用途
WO2021161232A1 (en) * 2020-02-12 2021-08-19 Lupin Limited Process for preparation of solriamfetol and intermediates thereof
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
KR102390194B1 (ko) 2020-08-03 2022-04-25 셀라이온바이오메드 주식회사 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2937119A (en) * 1959-06-11 1960-05-17 Carter Prod Inc Nu-monosubstituted-2, 2-dialkyl-1, 3-propanediol dicarbamates
KR0173862B1 (ko) * 1995-02-11 1999-04-01 조규향 O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법

Also Published As

Publication number Publication date
DE69618663T2 (de) 2002-08-14
EP0873308B1 (en) 2002-01-02
JP2000502364A (ja) 2000-02-29
CA2240060A1 (en) 1998-04-16
CN1204316A (zh) 1999-01-06
DE69618663D1 (de) 2002-02-28
CA2240060C (en) 2007-07-17
CN1076016C (zh) 2001-12-12
WO1998015526A1 (en) 1998-04-16
JP4068154B2 (ja) 2008-03-26
EP0873308A1 (en) 1998-10-28
PT873308E (pt) 2002-06-28
DK0873308T3 (da) 2002-04-22

Similar Documents

Publication Publication Date Title
ES2170878T3 (es) Compuestos de o-carbamoil-fenilalaninol y sus sales farmaceuticamente utiles.
ES2165485T3 (es) Compuestos de o-carbamoil-(d)-fenilalaninol y procedimiento para preparar los mismos.
PA8539401A1 (es) Quinazolinas como inhibidores de mmp-13
GT199900043A (es) Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxìlico.
PA8539501A1 (es) Compuestos triazolo como inhibidores de mmp
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
ES2164072T3 (es) Heterociclos no aromaticos que contienen nitrogeno sustituidos con bencilamino.
NZ336202A (en) Pure enantiomer aryl-cycloalkyl-hydroxycarboxylic acid esters and use in treating smooth muscle spasms and respiritory diseases
ES2089672T3 (es) N-fenilacetaminonitrilos y su empleo como productos intermedios para la sintesis de 3-aril-pirrolidin-2,4-dionas insecticidas y acaricidas.
ES2051719T3 (es) Un procedimiento para producir un compuesto de benzoilurea.
AR247402A1 (es) Un procedimiento para preparar antibioticos macrolidos c-20 aminosustituidos
ES2065755T3 (es) Derivados de 3-aminopiridacinas activos sobre el sistema nervioso central.
MY123467A (en) Preparation of sterically hindered amine ethers
ES2117281T3 (es) Nuevos analogos de la vitamina d.
ES2164366T3 (es) Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.
ES2179343T3 (es) Nuevos analogos de la vitamina d.
PA8563601A1 (es) Acidos-3-(imidazolil)-2- alcoxipropanoicos
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES8601202A1 (es) Procedimiento para la produccion de espirosuccinimidas
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES2158280T3 (es) Derivados de triazina.
ES2169044T3 (es) Nuevos esteres de acido nicotinico.
ES2154414T3 (es) Compuestos derivados de benceno sulfonamida, su preparacion y sus aplicaciones en terapeutica.
EP1433832A4 (en) PHOSPHORUS-CONTAINING CARBOXYLIC ACID DERIVATIVES, PROCESS FOR PREPARING THESE DERIVATIVES, AND FLAME RETARDANT SUBSTANCES
ES2169909T3 (es) 5-hidroximetil-2-aminotetralinas como agentes cardiovasculares.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 873308

Country of ref document: ES